• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMC 7.32% 7.6¢

IMMURON LIMITED - Corporate Spotlight

Immuron Limited is an Australia-based biopharmaceutical company focused on developing and... Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), IMM-529, and CampETEC.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

No Corporate Spotlight currently available.

(20min delay)
Last
7.6¢
Change
-0.006(7.32%)
Mkt cap ! $17.41M
Open High Low Value Volume
8.0¢ 8.1¢ 7.6¢ $138.6K 1.756M

Buyers (Bids)

No. Vol. Price($)
2 57477 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
7.8¢ 1417 1
View Market Depth
Last trade - 16.10pm 18/10/2024 (20 minute delay) ?
Last
7.7¢
  Change
-0.006 ( 4.94 %)
Open High Low Volume
8.0¢ 8.0¢ 7.6¢ 711302
Last updated 15.08pm 18/10/2024 ?
IMC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.